Neurofibromatosis

Neurofibromatosis (NF) is a group of three genetic conditions that cause tumors to grow on nerves. These tumors are usually non-cancerous (benign) but can affect many parts of the body, including the skin, bones, brain, and spinal cord. The severity and specific symptoms vary greatly among the three types: NF1, NF2, and schwannomatosis.

What is Neurofibromatosis?

Neurofibromatosis (NF) is a set of three distinct genetic disorders that cause tumors to form on nerve tissue. These growths, called neurofibromas or schwannomas, are typically non-cancerous but can lead to a range of health problems. The three main types are Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2), and schwannomatosis, each with unique characteristics.

Neurofibromatosis type 1 (NF1) is the most common form, affecting about 1 in 3,000 people. It often causes skin changes, such as light brown spots and small bumps, and can lead to bone problems or learning difficulties. Symptoms usually appear in childhood. Neurofibromatosis type 2 (NF2) is much rarer, affecting about 1 in 25,000 people. It primarily causes tumors to grow on the nerves leading to the inner ear, known as vestibular schwannomas. These tumors can cause hearing loss, ringing in the ears (tinnitus), and balance problems. NF2 symptoms typically emerge during the teenage years or early adulthood. Schwannomatosis is the rarest type, affecting about 1 in 40,000 people. It causes multiple painful tumors called schwannomas to develop on nerves throughout the body, but not usually on the nerves leading to the inner ear. The main symptom is often chronic, severe pain.

Symptoms

The symptoms of neurofibromatosis vary significantly depending on the type and which nerves are affected. Common signs can include skin spots, bumps under the skin, bone changes, and problems with hearing or vision. Symptoms often progress over time and can range from mild to severe.

For Neurofibromatosis type 1 (NF1), common signs include six or more flat, light brown spots on the skin, called café au lait spots, usually present by age 5. Freckling in the armpits or groin area is also typical. Soft, pea-sized bumps on or under the skin, called neurofibromas, often appear during puberty. Larger, more extensive tumors under the skin, known as plexiform neurofibromas, can sometimes cause disfigurement or press on organs. Other symptoms can include tiny, harmless bumps on the colored part of the eye (Lisch nodules), tumors on the optic nerve (optic gliomas) that may affect vision, bone deformities like a curved spine (scoliosis), and learning disabilities, which affect about half of people with NF1. Neurofibromatosis type 2 (NF2) is characterized by tumors on the nerves leading to the inner ear, called bilateral vestibular schwannomas, which usually affect both ears. These tumors can cause gradual hearing loss, ringing in the ears (tinnitus), and problems with balance. Other tumors, such as meningiomas (tumors on the brain or spinal cord lining) or schwannomas on other nerves, can lead to headaches, numbness, weakness, or pain. Clouding of the eye lens (cataracts) at a young age is also common. Schwannomatosis primarily causes chronic, often severe, pain due to the development of multiple schwannomas on nerves throughout the body. These tumors can also lead to numbness, tingling, or weakness in the affected areas. Unlike NF2, schwannomatosis does not typically involve vestibular schwannomas, meaning hearing and balance are usually not affected.

Causes & risk factors

Neurofibromatosis is caused by specific genetic mutations, meaning changes in certain genes. These mutations can be inherited from a parent or can occur spontaneously, without a family history. The primary risk factor is having a parent with neurofibromatosis.

Each type of neurofibromatosis is linked to a different genetic mutation. Neurofibromatosis type 1 (NF1) results from a mutation in the NF1 gene located on chromosome 17. Neurofibromatosis type 2 (NF2) is caused by a mutation in the NF2 gene on chromosome 22. Schwannomatosis is associated with mutations in the SMARCB1 or LZTR1 genes. These conditions are inherited in an autosomal dominant pattern. This means that if one parent has neurofibromatosis, each child has a 50% chance of inheriting the mutated gene and developing the condition. It's like flipping a coin for each child; there's an equal chance of inheriting the gene or not. However, about half of all neurofibromatosis cases are not inherited. Instead, they result from a new, spontaneous genetic mutation that occurs in the affected person's egg or sperm cells, or during early development. In these cases, there is no family history of the condition. The only known risk factor for developing neurofibromatosis is having a parent who has the condition.

How it's diagnosed

Diagnosing neurofibromatosis typically involves a physical exam, a review of your medical and family history, and specific diagnostic criteria based on symptoms. Imaging tests and genetic testing can also help confirm the diagnosis and identify the specific type of NF.

For Neurofibromatosis type 1 (NF1), a diagnosis is usually made based on a physical examination and specific signs, often by age 5. A person must meet at least two of the following criteria: six or more café au lait spots, two or more neurofibromas or one plexiform neurofibroma, freckling in the armpit or groin, an optic glioma, two or more Lisch nodules, certain bone abnormalities, or a parent, sibling, or child with NF1. Neurofibromatosis type 2 (NF2) is often diagnosed if a person has bilateral vestibular schwannomas, which are tumors on both nerves leading to the inner ear, typically identified with a magnetic resonance imaging (MRI) scan. Alternatively, a diagnosis can be made if a person has a first-degree relative (parent, sibling, or child) with NF2 and either a unilateral vestibular schwannoma (tumor on one inner ear nerve) or two other specific types of tumors, such as meningiomas, gliomas, or schwannomas. Schwannomatosis is diagnosed based on the presence of multiple schwannomas that are not vestibular schwannomas, the absence of evidence of vestibular schwannomas on an MRI, and the absence of a known NF2 mutation. Chronic pain is also a key feature. Genetic testing can confirm the specific gene mutation for all types of neurofibromatosis, which can be helpful for diagnosis, especially in unclear cases, or for family planning.

Treatment options

Currently, there is no cure for neurofibromatosis, so treatment focuses on managing symptoms and complications. This often involves regular monitoring, surgery to remove problematic tumors, and medications to address specific issues like pain or tumor growth. Support therapies are also crucial for improving quality of life.

Treatment for neurofibromatosis is highly individualized and depends on the type of NF and the specific symptoms a person experiences. Regular monitoring by a team of specialists, including neurologists, ophthalmologists, and audiologists, is essential. This monitoring involves routine check-ups, eye exams, hearing tests, and MRI scans to detect new tumors or changes in existing ones. Surgery is a common treatment option, especially for tumors that are causing pain, disfigurement, or pressing on vital nerves or organs. For example, surgery may be used to remove vestibular schwannomas in NF2 to preserve hearing, or to remove plexiform neurofibromas in NF1 that are causing problems. However, removing all tumors may not always be possible or advisable. Medications can help manage certain symptoms. For instance, pain relievers are often used for the chronic pain associated with schwannomatosis. In rare cases where tumors become cancerous, chemotherapy or radiation therapy may be considered. A specific medication, selumetinib (Koselugo), is approved by the FDA for children with NF1 who have inoperable plexiform neurofibromas, helping to shrink these tumors. Supportive therapies play a significant role in managing the condition. Physical therapy can help with muscle weakness or balance issues, while occupational therapy can assist with daily activities. Speech therapy and educational support are often beneficial for children with learning disabilities related to NF1. Ongoing research through clinical trials continues to explore new treatment approaches and medications for all types of neurofibromatosis.

Recovery & outlook

The recovery and long-term outlook for neurofibromatosis vary widely, depending on the specific type and severity of the condition. Many people with NF1 live full lives, while NF2 and schwannomatosis can present more significant challenges. Regular medical care and support are key to managing the condition effectively.

For individuals with Neurofibromatosis type 1 (NF1), the outlook is generally good, and most people live full and productive lives. However, they may face various complications, such as learning disabilities, bone problems, or, less commonly, the development of cancerous tumors. Life expectancy for people with NF1 may be slightly reduced compared to the general population, primarily due to potential complications like cancer, heart disease, or blood vessel issues. Neurofibromatosis type 2 (NF2) can lead to more significant challenges, including severe hearing loss, vision problems, and other neurological issues due to tumors on the brain and spinal cord. While treatments can manage symptoms and complications, NF2 can significantly impact quality of life and may reduce life expectancy. Regular monitoring and early intervention are crucial for managing the progression of the disease. For those with schwannomatosis, the primary challenge is often chronic and severe pain caused by the tumors. While the tumors are usually benign and the condition is not typically life-threatening, managing the pain can be complex and require ongoing medical attention. The impact on daily life depends heavily on the severity and location of the pain. Regardless of the type, living with neurofibromatosis often involves ongoing medical care and support. Genetic counseling can help families understand the inheritance patterns and risks. Support groups and mental health professionals can provide valuable emotional and practical support for individuals and their families coping with the challenges of the condition.

When to see a doctor

You should see a doctor if you or your child develop any signs or symptoms of neurofibromatosis, such as multiple light brown skin spots or new skin bumps. Prompt medical evaluation is important for diagnosis and to begin appropriate management. Certain sudden or severe symptoms warrant immediate medical attention.

It is important to consult a healthcare provider if you notice any potential signs of neurofibromatosis in yourself or your child. This includes the appearance of six or more café au lait spots, especially if they are larger than a quarter inch in children or half an inch in adults. You should also seek medical advice if you notice new or growing soft bumps on or under the skin (neurofibromas), or if there is freckling in unusual areas like the armpits or groin. Additionally, if you experience changes in hearing, such as ringing in the ears (tinnitus) or hearing loss, or if you develop vision problems, balance issues, or unexplained chronic pain, these symptoms warrant a medical evaluation. Early diagnosis allows for timely monitoring and management of the condition, which can help prevent or reduce the severity of complications. Certain symptoms require immediate medical attention. You should seek emergency care if you experience a sudden worsening of pain, new or rapidly increasing weakness or numbness, sudden changes in vision or hearing, or any new lump that is growing quickly or is very painful. Severe headaches or seizures are also red-flag symptoms that need urgent medical evaluation to rule out serious complications.

Frequently asked questions

Can neurofibromatosis be prevented?

No, neurofibromatosis cannot be prevented because it is a genetic condition caused by specific gene mutations. These mutations can be inherited from a parent or occur spontaneously, meaning they happen randomly without a family history.

Is neurofibromatosis always serious?

The seriousness of neurofibromatosis varies greatly. Some people have mild symptoms that don't significantly impact their lives, while others experience severe complications affecting multiple body systems. The specific type of NF also influences its severity.

Can neurofibromas become cancerous?

While most neurofibromas are non-cancerous (benign), there is a small risk that some, particularly plexiform neurofibromas in NF1, can transform into a malignant (cancerous) tumor. Regular monitoring helps detect any suspicious changes early.

Does neurofibromatosis affect intelligence?

Neurofibromatosis type 1 (NF1) can cause learning disabilities in about half of affected individuals, but it typically does not lead to intellectual disability. NF2 and schwannomatosis usually do not directly affect intelligence.

Is there a cure for neurofibromatosis?

Currently, there is no cure for any type of neurofibromatosis. Treatment focuses on managing symptoms, addressing complications, and improving quality of life through regular monitoring, surgery, medications, and supportive therapies.

How common is neurofibromatosis?

Neurofibromatosis type 1 (NF1) is the most common, affecting about 1 in 3,000 people. Neurofibromatosis type 2 (NF2) is rarer, affecting about 1 in 25,000 people. Schwannomatosis is the rarest, occurring in about 1 in 40,000 people.

Sources

• MedlinePlus — Neurofibromatosis
• Mayo Clinic — Neurofibromatosis
• Cochrane Library — Neurofibromatosis